ResMed RMD Sleep And Breathing Health — Cost of Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by ResMed in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: ResMed’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about ResMed's sleep and breathing health — cost of sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ResMed's sleep and breathing health — cost of sales?
- ResMed (RMD) reported sleep and breathing health — cost of sales of $479.19M in Q1 2026.
- How has ResMed's sleep and breathing health — cost of sales changed year-over-year?
- ResMed's sleep and breathing health — cost of sales increased by 2.6% year-over-year, from $466.98M to $479.19M.
- What is the long-term trend for ResMed's sleep and breathing health — cost of sales?
- Over 2 years (2023 to 2025), ResMed's sleep and breathing health — cost of sales has grown at a 5.7% compound annual growth rate (CAGR), from $1.66B to $1.85B.
- What does sleep and breathing health — cost of sales mean?
- Represents the direct costs attributable to the production and delivery of goods and services within the Sleep and Breathing Health segment. This includes raw materials, labor, and manufacturing overhead directly associated with respiratory devices and accessories. It serves as a primary indicator of production efficiency and direct margin pressure within the core business unit.